By asianet
The world’s leading antioxidant supplement with Masquelier’s(R) Original OPCs. Adds life to your years. June 3rd, 2022: Partnering with Australian swimming legend Ian Thorpe, Anthogenol(R) looks to continue to set the bar globally for antioxidant supplements that offer real, tangible results. The Olympian perfectly represents the brand’s prominence, authority and credibility in the health and … Continued
By asianet
– In hospitalized patients with COVID-19 Pneumonia, the rates of clinical events among those treated with Reparixin (n=36) were statistically significantly lower than standard of care (n=19). – The study is the first evaluation of the efficacy and safety of Reparixin an IL-8 inhibitor in patients with severe COVID-19 pneumonia. – Results from the Phase … Continued
By asianet
– In Australia, Nuvaxovid(TM) is the first protein-based COVID-19 vaccine registered for use as a booster regardless of previous vaccine history Novavax, Inc. (NASDAQ: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Australian Therapeutic Goods Administration (TGA) has granted provisional registration of Nuvaxovid(TM) (NVX-CoV2373) … Continued
By asianet
*NSW Home Support Services joins General Homecare group* *First non-Victorian brand to be part of General Homecare’s “For locals, by locals” charter* 30 May 2022, Melbourne. General Homecare, a leading homecare and Aged Care provider, has announced that NSW Home Support Services (HSS) will join the group, expanding their family of locally trusted care service organisations … Continued
By asianet
Today Inteleos announced a pilot project with Wuqu’ Kawoq | the Maya Health Alliance as the selection of the Point-of-Care Ultrasound (POCUS) Certification Academy’s 2022 MissionPOCUS(TM) project. As the fifth MissionPOCUS project since the initiative’s inception in 2018, Inteleos’ MissionPOCUS will award the Guatemalan organization a grant to establish an innovative education program aimed to … Continued
By asianet
Nippon Express Co., Ltd. (hereinafter “Nippon Express”), a group company of Nippon Express Holdings, Inc., launched on May 30 a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry. Logo: https://kyodonewsprwire.jp/img/202206072182-O1-1zA70963 Photo: Products to be handled (examples) https://kyodonewsprwire.jp/img/202206072182-O2-zds69HQG Photo: Envisioned uses for service https://kyodonewsprwire.jp/img/202206072182-O3-9s8evO6B As a … Continued
By asianet
– 11 Organisations Provide Examples, Learnings and Recommendations on How to Improve Nutrition at Work The Consumer Goods Forum (CGF) and the Global Alliance for Improved Nutrition (GAIN) ( https://www.gainhealth.org/ ), as part of the Workforce Nutrition Alliance (WNA) ( https://workforcenutrition.org/#/home ), are thrilled to publish the Workforce Nutrition Alliance Case Study Booklet ( https://tinyurl.com/2p94sjjd … Continued
By asianet
Today, Medison Pharma (“Medison”), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, is pleased to announce the approval of KIMMTRAK(R) (tebentafusp) by Health Canada and Therapeutics Goods Administration (TGA) for the treatment of unresectable or metastatic uveal melanoma (mUM), a rare and aggressive form of melanoma … Continued
By asianet
LenioBio GmbH today announced it had achieved a key milestone for the company with the successful linear scaling of its cell-free protein synthesis (CFPS) platform, ALiCE(R), to an industrial scale. Through a series of breakthrough developments, ALiCE(R) can now be used to produce up to 3g/litre of complex, functional proteins in reaction volumes of up … Continued
By asianet
–Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee –If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the U.S. Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing … Continued